000999:SZSEChina Resources Sanjiu Medical & Pharmaceutical Co., Ltd. Analysis

China Resources Sanjiu Medical & Pharmaceutical trades at CNY 24.43, well below its 20‑day SMA of 25.67 and the 30‑day DCF fair value of 68, indicating a substantial valuation gap of over 50%. The stock is deeply oversold with an RSI of 23 and a bearish MACD histogram, yet it sits atop a clear support level near 24.38. Fundamentals bolster the case: revenue grew 18.6% YoY, PE is 12.6 versus an industry average of 27.3, and the dividend yield stands at a robust 5.22% with a modest payout ratio of 36%. Despite a negative free cash flow, operating cash flow remains strong and the balance sheet shows net cash, mitigating concerns over the high debt‑to‑equity ratio. Overall, the combination of technical oversold conditions, strong dividend, and a massive upside potential supports a bullish outlook.